Hims and other telehealth companies make finasteride easy to get and don’t have to disclose side effects in ads.

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

Former US Army Sgt. Mark Millich’s sex drive plummeted — and his genitals shrank and changed shape after taking popular hair-loss drug finasteride.

Telehealth companies like Hims & Hers (HIMS) are aggressively marketing hair-loss medications to young men, with some patients saying they ...

The ad sparked controversy for promoting ... which will not be offered after the first quarter, Okupe said. Hims launched in 2017, selling generic hair loss, sexual health, and skincare drugs ...

While Hims offers more options for sexual health and hair loss, Roman offers more options overall. Here’s our full breakdown of Hims vs. Roman for erectile dysfunction, hair loss, and more.

But with GLP-1 sales vanishing, Hims is left banking on generic weight-loss pills and its core business in hair-loss and ED treatments. While that business is solid, it doesn't justify the lofty ...

Founded in 2017, Hims is a telemedicine platform that offers medical services and treatments related to sexual health, hair loss, anxiety, skin care, and more. Hims connects its customers with ...

Hims & Hers Health stock has surged 212% since ... announced its plans to expand into hair loss and ED (erectile dysfunction) treatment sectors through its One Medical telehealth service.

Earlier this month, Hims ran a Super Bowl ad touting the affordability of its weight loss drugs compared to those sold by big pharmaceutical companies. The ad sparked controversy for promoting ...